DaVita Inc. Files 8-K

TL;DR

DaVita filed an 8-K, something happened, details TBD.

AI Summary

DaVita Inc. filed an 8-K on August 20, 2025, reporting an event under "Other Events." The filing does not contain specific details about the event, dollar amounts, or names beyond the company itself.

Why It Matters

This filing indicates a material event has occurred for DaVita Inc., requiring disclosure to investors, though the specifics are not yet detailed.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' and does not contain specific financial or operational information that would immediately indicate risk.

Key Players & Entities

• DAVITA INC. (company) — Registrant
• August 20, 2025 (date) — Date of Report
• 2000 16th Street Denver, CO 80202 (address) — Principal executive offices

FAQ

From the Filing

0000927066-25-000154.txt : 20250820 0000927066-25-000154.hdr.sgml : 20250820 20250820160940 ACCESSION NUMBER: 0000927066-25-000154 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20250820 ITEM INFORMATION: Other Events FILED AS OF DATE: 20250820 DATE AS OF CHANGE: 20250820 FILER: COMPANY DATA: COMPANY CONFORMED NAME: DAVITA INC. CENTRAL INDEX KEY: 0000927066 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MISC HEALTH & ALLIED SERVICES, NEC [8090] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 510354549 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-14106 FILM NUMBER: 251236890 BUSINESS ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 BUSINESS PHONE: 310-536-2668 MAIL ADDRESS: STREET 1: 2000 16TH STREET CITY: DENVER STATE: CO ZIP: 80202 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA HEALTHCARE PARTNERS INC. DATE OF NAME CHANGE: 20121107 FORMER COMPANY: FORMER CONFORMED NAME: DAVITA INC DATE OF NAME CHANGE: 20001005 FORMER COMPANY: FORMER CONFORMED NAME: TOTAL RENAL CARE HOLDINGS INC DATE OF NAME CHANGE: 19950524 8-K 1 dva-20250820.htm 8-K dva-20250820 0000927066 false 0000927066 2025-08-20 2025-08-20   UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549   Form 8-K     CURRENT REPORT   Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934   Date of Report (date of earliest event reported): August 20, 2025     DAVITA INC. (Exact name of registrant as specified in its charter)   DE 1-14106 51-0354549 (State or other jurisdiction of incorporation) (Commission File Number) (IRS Employer Identification No.)   2000 16th Street Denver, CO 80202 (Address of principal executive offices including Zip Code)   ( 720 ) 631-2100 (Registrant’s telephone number, including area code)   Not applicable (Former name or former address, if changed since last report)   Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐     Written communications pursuant to Rule 425 under the Securities Act (17 CFR 240.425) ☐     Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐     Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐     Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class:   Trading symbol(s): Name of each exchange on which registered: Common Stock, $0.001 par value   DVA New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). ☐     Emerging growth company If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01. Other Events. On August 20, 2025, the board of directors (the “Board”) of DaVita Inc. (the “Company”) increased the authorization under the Company’s existing share repurchase program by $2,000,000,000 in additional repurchasing authority (the “New Authorization”). The amount of shares of common stock authorized to be repurchased under the New Authorization does not include the amount remaining under the Company’s existing share repurchase program autho